logo IDIBELL
Català  |   Castellano  |   English
Search
The InstituteResearchWhat's onPlatformsJoin usTools
 

News

boto imprimir
Date: 28/05/2018

Green light to REMAB, a new IDIBELL Spin-Off


REMAB Therapeutics, the new IDIBELL Spin-off, was officially launched by the end of April 2018. The company has doctors Rafael Mañez (IP) and Daniel Bello, from the research group on innate immunity and pathology of the critical patient, as founding partners, together with IDIBELL.

 

REMAB’s main objective is the development of a new molecule for the preventive treatment of nosocomial infections by Gram negative bacteria. The treatment is based on the systemic elimination of so-called "non-neutralizing” natural antibodies that favor pathogen growth, interfering with the natural response of the immune system. It is a new approach with an innovative mechanism of action that will open a new vision in the way of treating and / or preventing various pathologies.

 

A Spin-off is a small start-up company, created in order to develop and / or exploit products or services based on technologies or knowledge that arise from research activities carried out in a public or private research center. At the moment, REMAB is the seventh spin-off created in IDIBELL, and one of the five active ones. Its capitalization has been possible thanks to the investment of Business Angels and the promoter team.





foto REMAB Therapeutics
REMAB Therapeutics

Share/Bookmark
 
© 2018 Institut d'Investigació Biomèdica de Bellvitge



Results by pageInitial date
Select date
TitleFinal date
Select date
Search


Your password is about to expire. Please, write in a new password to continue

Remember this password allows you to access to all IDIBELL’s web applications

New password:
Confirm new password:

Accept



Your password is about to expire. Please, write in a new password to continue

Remember this password allows you to access to all IDIBELL’s web applications

New password:
Confirm new password:

Accept


Cancell

Passwords doesn’t match
The password must have at least 6 characters
The new password can not contain special characters
User register

Name
Surname
Second Surname
E-mail
User
Password
Language


Accept


Cancell




Encara no heu contestat l'enquesta de satisfacció sobre la píndola formativa sobre patents. No trigareu més de cinc minuts a fer-ho. La vostra opinió és molt important per millorar l’IDIBELL.

Voleu fer l’enquesta ara?

Yes

No




Further personal and contact information is needed to maintain IDIBELL databases.

Do you wish to fill the form now?

Yes

No





Please, remember to introduce your holiday’s planning in the application

Accept

Cancell